Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality

Abstract

ACP Journal Club17 April 2012Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortalityPhilipp Dahm, MD, MHSc, FACSPhilipp Dahm, MD, MHSc, FACSUniversity of Florida, Gainesville, Florida, USA (P.D.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-8-201204170-02002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationChou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2011;155:762-71. https://pubmed.ncbi.nlm.nih.gov/21984740Clinical Impact RatingsGIM/FP/GP: Oncology: References1 US Preventive Services Task Force. Screening for prostate cancer: draft recommendation statement. Oct 2011. www.uspreventiveservicestaskforce.org/uspstf12/prostate/draftrecprostate.htm (accessed 24 Feb 2012). Google Scholar2 NIH Consensus Development Program. NIH state-of-the-science conference: Role of active surveillance in the management of men with localized prostate cancer. Dec 2011. www.consensus.nih.gov/2011/prostate.htm (accessed 24 Feb 2012). Google Scholar Author, Article, and Disclosure InformationAuthors: Philipp Dahm, MD, MHSc, FACSAffiliations: University of Florida, Gainesville, Florida, USA (P.D.)This article was published at Annals.org on 3 April 2012. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 17 April 2012Volume 156, Issue 8Page: JC4-2KeywordsAntigensCancer screeningCancer treatmentMortalityNumber needed to screenProstate cancerResearch designResearch quality assessmentSystematic reviews ePublished: 17 April 2012 Issue Published: 17 April 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...